276 related articles for article (PubMed ID: 27148941)
1. Concomitant Presentation of Hemophagocytic Lymphohistiocytosis and Posttransplant Lymphoproliferative Disease-Like Lymphoma in a Mildly Immunosuppressed Leukemia Patient: An Unusual Association.
Sinno MG; Rosen D; Wittler R
Pediatr Blood Cancer; 2016 Aug; 63(8):1474-6. PubMed ID: 27148941
[TBL] [Abstract][Full Text] [Related]
2. Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights.
Papageorgiou SG; Tsiodras S; Siakallis G; Bazani E; Spathis A; Poulakou G; Korkolopoulou P; Panayiotides I; Pappa V
Pathol Res Pract; 2016 Dec; 212(12):1194-1198. PubMed ID: 28340951
[TBL] [Abstract][Full Text] [Related]
3. Treatment of rare co-occurrence of Epstein-Barr virus-driven post-transplant lymphoproliferative disorder and hemophagocytic lymphohistiocytosis after allogeneic stem cell transplantation.
Weber T; Wickenhauser C; Monecke A; Gläser C; Stadler M; Desole M; Ligeti K; Behrmann C; Müller-Tidow C; Müller LP
Transpl Infect Dis; 2014 Dec; 16(6):988-92. PubMed ID: 25179757
[TBL] [Abstract][Full Text] [Related]
4. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
Su Y; Zhou X; Zhang L; Zhang R
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767
[TBL] [Abstract][Full Text] [Related]
5. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
[TBL] [Abstract][Full Text] [Related]
6. The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.
Yamamoto N; Nishimura N; Takeuchi M; Ito T; Yokozaki H; Hirase S; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Nishio H; Matsuo M; Imadome K; Iijima K
Eur J Pediatr; 2014 Dec; 173(12):1615-8. PubMed ID: 24169729
[TBL] [Abstract][Full Text] [Related]
7. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy].
Ikeda M; Oba R; Yoshiki Y; Shingaki S; Takei T; Miyazaki K; Abe Y; Tsukada N; Ishida T; Suzuki K
Rinsho Ketsueki; 2017; 58(3):216-221. PubMed ID: 28381688
[TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia following chemotherapy for EBV-associated hemophagocytic lymphohistiocytosis.
Sathiyamoorthy S; Shad A; Ozdemirli M
Pediatr Blood Cancer; 2011 May; 56(5):850-2. PubMed ID: 21370422
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.
Yatsushiro Y; Nishikawa T; Saito A; Nakazawa Y; Imadome KI; Nakagawa S; Kodama Y; Okamoto Y; Kanegane H; Kawano Y
J Pediatr Hematol Oncol; 2019 Jan; 41(1):e44-e46. PubMed ID: 29324572
[TBL] [Abstract][Full Text] [Related]
10. Dermatopathic lymphadenitis with generalized erythroderma in a patient with epstein-barr virus-associated hemophagocytic lymphohistiocytosis.
Lee WJ; Lee DW; Kim CH; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Am J Dermatopathol; 2010 Jun; 32(4):357-61. PubMed ID: 20010284
[TBL] [Abstract][Full Text] [Related]
11. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
12. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.
Balamuth NJ; Nichols KE; Paessler M; Teachey DT
J Pediatr Hematol Oncol; 2007 Aug; 29(8):569-73. PubMed ID: 17762500
[TBL] [Abstract][Full Text] [Related]
13. Severe hemorrhagic coagulopathy with hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus-associated T-cell lymphoproliferative disorder.
Nawathe PA; Ravindranath TM; Satwani P; Baird JS
Pediatr Crit Care Med; 2013 May; 14(4):e176-81. PubMed ID: 23439459
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
Suzumiya J; Ohshima K; Kanda M; Kumagawa M; Nagano M; Hirata M; Nawa Y; Tamura K; Kikuchi M
Leuk Lymphoma; 2000 May; 37(5-6):593-604. PubMed ID: 11042520
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of hemophagocytic syndrome in a patient with T cell lymphoma, EBV infection, and bone marrow necrosis: A case report.
Xu L; Liu X; Wang Y; Wang Y; Chu X; Chen L
Medicine (Baltimore); 2022 Mar; 101(9):e28943. PubMed ID: 35244052
[TBL] [Abstract][Full Text] [Related]
17. A boy with fever, lymphadenopathy, hepatosplenomegaly, and lymphocytosis.
Kaza U; Knight AK; Jeroudi M; Bocchini JA; Anga A; Bahna SL
Allergy Asthma Proc; 2008; 29(2):216-20. PubMed ID: 18430321
[TBL] [Abstract][Full Text] [Related]
18. The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis.
Bosman G; Langemeijer SM; Hebeda KM; Raemaekers JM; Pickkers P; van der Velden WJ
Neth J Med; 2009 Sep; 67(8):364-5. PubMed ID: 19767670
[No Abstract] [Full Text] [Related]
19. Epstein-Barr virus infection is an important cause of hemophagocytic lymphohistiocytosis during chemotherapy for lymphoma.
Jin Z; Wang Y; Wei N; Wang Z
Infect Dis Now; 2021 May; 51(3):310-311. PubMed ID: 33934811
[No Abstract] [Full Text] [Related]
20. Hemophagocytic Lymphohistiocytosis: A Dangerous Intruder in Pediatric Acute Lymphoblastic Leukemia.
Martínez-Romera I; Villa M; Areal P; Rodrigo E; Herrero B; López-Ibor B
J Pediatr Hematol Oncol; 2018 Mar; 40(2):e108-e110. PubMed ID: 28859036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
